drugset / Trial / NCT02004860

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

NCT02004860

Phase 3 Completed 120 enrolled University Hospital, Rouen
RandomizedParallel-groupDouble-blindTreatment

Summary

Seborrheic dermatitis is a chronic inflammatory dermatological disease, evolving by relapses, affecting mainly the face and scalp. It would be important to have a maintenance treatment for severe forms of seborrheic dermatitis witch is both effective and relatively well tolerated to reduce the frequency of relapses, prolong remissions obtained after attack treatment and reduce the use of topical steroids.

Timeline

Start
2014-01
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciclopirox Olamine Unknown 1 % Topical
Subject Tacrolimus Small molecule 0.1 % Topical

Indications